NCT01184885 2025-05-04
A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy
Thomas Jefferson University
Phase EARLY_PHASE1 Completed
Thomas Jefferson University
University of Chicago
University of Rochester
University of Nebraska
Rutgers, The State University of New Jersey